PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues – A population pharmacokinetic/pharmacodynamic analysis of rucaparib

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 89-98

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modeling of Total Lymphocytes and Selected Subtypes After Oral Budesonide

By Stark Jeffrey   Werner Sybille   Homrighausen Susanne   Tang Yufei   Krieg Michael   Derendorf Hartmut   Moellmann Helmut   Hochhaus Guenther  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 4, 2006-08 ,pp. : 441-459

Springer Publishing Company

Access to resources Recommend Favorite

Population Pharmacokinetic–Pharmacodynamic Modeling of Subcutaneous and Pulmonary Insulin in Rats

By Gopalakrishnan Mathangi   Suarez Sandra   Hickey Anthony   Gobburu Jogarao  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 3-4, 2005-08 ,pp. : 485-500

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modeling of GLP-1 in Healthy Rats

By Cao Yanguang   Gao Wei   Jusko William  

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1078-1086

Springer Publishing Company

Access to resources Recommend Favorite

Mixture Modeling for the Detection of Subpopulations in a Pharmacokinetic/Pharmacodynamic analysis

By Lemenuel-diot Annabelle   Laveille Christian   Frey Nicolas   Jochemsen Roeline   Mallet Alain  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 2, 2007-04 ,pp. : 157-181

Springer Publishing Company

Access to resources Recommend Favorite